GlassScriptPhysician profile
Zachary Matthay
NPI 1730541947
$1,661.48
in general payments reported to CMS, 2019-2025
7 companies · $342 in 2025
The $342 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2023: $361 · 2024: $723 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747 · Education: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.30 |
| Education | $678.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $821.90 | 2023-2024 | Endurant Iis |
| Cook Medical LLC | $254.59 | 2025 | Zilver Ptx, Zenith Spiral-Z, Zenith Alpha |
| Medtronic Vascular, INC. | $235.80 | 2019 | |
| Shape Memory Medical INC. | $133.33 | 2024 | Impede Embolization Plug |
| Silk Road Medical, INC. | $128.39 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Stryker Corporation | $49.21 | 2025 | Flowtriever, Artix Mt |
| Terumo Medical Corporation | $38.26 | 2025 | Azur Cx Detachable, Metacross Otw, Navicross |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Matthay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.